Chengdu Kanghong Pharmaceutical Group Co., Ltd (SHE: 002773)
China
· Delayed Price · Currency is CNY 19.08
-0.52 (-2.65%)
Jan 2, 2025, 3:04 PM CST
Chengdu Kanghong Pharmaceutical Group Revenue
Chengdu Kanghong Pharmaceutical Group had revenue of 1.12B CNY in the quarter ending September 30, 2024, with 3.59% growth. This brings the company's revenue in the last twelve months to 4.37B, up 16.34% year-over-year. In the year 2023, Chengdu Kanghong Pharmaceutical Group had annual revenue of 3.96B with 16.77% growth.
Revenue (ttm)
4.37B
Revenue Growth
+16.34%
P/S Ratio
4.01
Revenue / Employee
1.02M
Employees
4,289
Market Cap
17.55B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 3.96B | 568.43M | 16.77% |
| Jan 1, 2023 | 3.39B | -216.32M | -6.00% |
| Jan 1, 2022 | 3.61B | 309.92M | 9.40% |
| Dec 31, 2020 | 3.30B | 38.00M | 1.17% |
| Dec 31, 2019 | 3.26B | 339.98M | 11.65% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| Jiangsu Hengrui Medicine | 26.00B |
| WuXi AppTec | 38.50B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
| Aier Eye Hospital Group | 20.62B |
| Yunnan Baiyao Group Co.,Ltd | 39.34B |
| Shanghai United Imaging Healthcare | 10.93B |
| Beijing Wantai Biological Pharmacy Enterprise | 2.49B |